AI assistant
SOLESENCE, INC. — Director's Dealing 2008
Jan 23, 2008
33563_dirs_2008-01-23_1c625c76-787f-4ba1-84c3-cb0f9a2fb8ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2008-01-22
Reporting Person: PERKINS DONALD S (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-01-22 | Stock Option (right to buy) | $3.13 | A | 15000 | Acquired | 2018-01-22 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 42144 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.50 | 2008-10-29 | Common Stock (25000) | 20000 | Direct |
| Stock Option (right to buy) | $5.25 | 2008-06-10 | Common Stock (2000) | 667 | Direct |
| Stock Option (right to buy) | $5.75 | 2008-02-19 | Common Stock (10000) | 3334 | Direct |
| Stock Option (right to buy) | $1.75 | 2009-07-27 | Common Stock (10000) | 6667 | Direct |
| Stock Option (right to buy) | $9.92 | 2011-06-05 | Common Stock (2000) | 2000 | Direct |
| Stock Option (right to buy) | $3.78 | 2012-11-25 | Common Stock (2000) | 2000 | Direct |
| Stock Option (right to buy) | $5.07 | 2013-06-26 | Common Stock (2000) | 2000 | Direct |
| Deferred Common Stock | $ | Common Stock (9290) | 9290 | Direct |
Footnotes
F1: Subject to certain restrictions, beginning on this date, options vest in five equal installments.
F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F3: Subject to certain restrictions, beginning on this date, options vest in two equal annual installments.
F4: Each share of deferred common stock represents a right to receive one share of common stock.
F5: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.